Purdy B H, Field F J
J Clin Invest. 1984 Aug;74(2):351-7. doi: 10.1172/JCI111430.
Parabiont rats were used to study the regulation of intestinal cholesterol synthesis (3-hydroxy-3-methylglutaryl coenzyme A [HMG-CoA] reductase activity) and esterification (acylcoenzyme A/cholesterol acyltransferase [ACAT] activity) by lipoproteins and micellar cholesterol. The parabiont rat model offers a unique way to observe changes in cholesterol metabolism in the intestine, independently of luminal factors. In one group of six surgically joined pairs, one animal was fed rat chow and 0.1% propylthiouracil (PTU). Its joined mate was fed rat chow, 0.1% PTU, 5% lard, and 0.3% taurocholic acid. In another group of five pairs, one rat was fed rat chow, 0.1% PTU, 5% lard, 0.3% taurocholic acid, plus 1% cholesterol. Its joined mate was fed the same diet except the cholesterol was deleted. Serum cholesterol changes were equal between members of a given pair, attesting to their common circulation. The administration of PTU itself caused a significant elevation of serum cholesterol. When one parabiont ingested cholesterol, serum cholesterol concentrations increased significantly for both pair members compared with control pairs not ingesting cholesterol. Hepatic and intestinal HMG-CoA reductase activities were significantly decreased in rats fed the diet containing cholesterol. ACAT activities in both organs were markedly increased. This supports previous data that suggest that dietary or luminal cholesterol affects both HMG-CoA reductase and ACAT activity in the small intestine. Moreover, in rats that were hypercholesterolemic but not ingesting dietary cholesterol, hepatic and intestinal reductase activities were decreased and ACAT activities were increased compared with the control animals. Intestinal microsomal cholesterol content was increased only in rats fed cholesterol. No changes in intestinal microsomal cholesterol were observed in the other animals. The data suggest that intestinal HMG-CoA reductase and ACAT activities are regulated by plasma lipoproteins independently of luminal factors. This nonluminal regulatory effect occurs without a measurable contribution to the intestinal microsomal cholesterol pool.
联体大鼠被用于研究脂蛋白和微胶粒胆固醇对肠道胆固醇合成(3-羟基-3-甲基戊二酰辅酶A [HMG-CoA]还原酶活性)和酯化(酰基辅酶A/胆固醇酰基转移酶[ACAT]活性)的调节作用。联体大鼠模型提供了一种独特的方式,可独立于肠腔因素观察肠道胆固醇代谢的变化。在一组六对通过手术连接的联体大鼠中,一只动物喂食大鼠饲料和0.1%丙硫氧嘧啶(PTU)。其联体伙伴喂食大鼠饲料、0.1% PTU、5%猪油和0.3%牛磺胆酸。在另一组五对联体大鼠中,一只大鼠喂食大鼠饲料、0.1% PTU、5%猪油、0.3%牛磺胆酸,外加1%胆固醇。其联体伙伴喂食相同的饮食,但不含胆固醇。给定联体对的成员之间血清胆固醇变化相同,证明它们有共同的循环系统。PTU本身的给药导致血清胆固醇显著升高。当一个联体大鼠摄入胆固醇时,与未摄入胆固醇的对照联体对相比,两个联体成员的血清胆固醇浓度均显著增加。喂食含胆固醇饮食的大鼠肝脏和肠道HMG-CoA还原酶活性显著降低。两个器官中的ACAT活性均明显增加。这支持了先前的数据,即饮食或肠腔胆固醇会影响小肠中的HMG-CoA还原酶和ACAT活性。此外,与对照动物相比,在高胆固醇血症但未摄入饮食胆固醇的大鼠中,肝脏和肠道还原酶活性降低,ACAT活性增加。仅在喂食胆固醇的大鼠中,肠道微粒体胆固醇含量增加。在其他动物中未观察到肠道微粒体胆固醇的变化。数据表明,肠道HMG-CoA还原酶和ACAT活性受血浆脂蛋白调节,独立于肠腔因素。这种非肠腔调节作用在未对肠道微粒体胆固醇池产生可测量贡献的情况下发生。